Clinical Trial Update: A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

View source ↗

Summary

Longitudinal, observational study in the United States comparing real-world experiences of participants with Stage 2 Type 1 diabetes who were treated with tepli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Teplizumab (Teplizumab)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes | Status: RECRUITING